Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Bacil Pharma Ltd Stock Analysis

Small Cap
Evaluated by 154 users | BSE: 524516 | NSE: |
Pharmaceuticals & Drugs
Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.Business profile:The company manufactures bulk pharmaceutical/ chemical manufacturing heavy, medium and fine chemicals. The Lote-Parshuraram plant...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed -0.09%0.65%-0.05%-0.9%-0.48%-1.01%-1.12%-29.34%-10.88%-7.09%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 00.51.100000000
Y-o-Y Gr. Rt.-4500%130.4%-100%NANANANANANA-
Adjusted EPS (Rs.) -0.010.08-0.01-0.1-0.05-0.11-0.13-2.27-0.39-0.23-0.44
Y-o-Y Gr. Rt.-NA-112.5%NANANANANANANA-
Book Value per Share (Rs.) 10.110.1710.139.959.898.619.842.722.161.270.83
Adjusted Net Profit 000-0.10-0.1-0.1-1.3-0.2-0.10
Net Op. Cash Flow (Rs. Cr.) 0-0.30.1-0.10.30.101.4-0.3-0.4-
Debt to Cash Flow from Ops 4.36-1.270-1.610.554.54-66.570-0.32-0.45-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Bacil Pharma Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%NANANA
Adjusted EPS NANANANA
Book Value per Share -20.6-33.7-49.5-41.2
Share Price 1.4% -3.7% 16.8% 20.6%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) -0.090.67-0.06-0.91-0.49-1.04-1.17-30.78-11.14-8.06-41.9
Operating Profit Margin (%) -986.26-0.4-0.3200000000
Net Profit Margin (%) -103.099.69-0.3500000000
Debt to Equity 0.010.0500.010.020.050.0500.050.12-
Working Capital Days 21,1524872790000000-
Cash Conversion Cycle 4162351000000000-
Loading price chart...
Entity Percentage Holding
Promoters 42.67%
Non-Institutions 57.33%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Bacil Pharma Ltd's earnings have grown by 0%, whereas share price has declined -3.7% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.

Bacil Pharma Ltd share price has appreciated 0.9% annually (CAGR) over the past ten years.

Data is not available for this company.

Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Business profile:

The company manufactures bulk pharmaceutical/ chemical manufacturing heavy, medium and fine chemicals. The Lote-Parshuraram plant also has manufacture facility for herbal extract and drug intermediates.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback